Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grubbs

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Oncology Reports|January 14, 2004
Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer preventionMark B Cope, Vernon E Steele, Ronald A Lubet, et al.
Molecular Cancer Therapeutics|February 14, 2016
Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic MalignanciesAlicia M Waters, Jerry E Stewart, Venkatram R Atigadda, et al.
Cancer Research|December 1, 1978
Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamineP J Becci, H J Thompson, C J Grubbs, et al.
Molecular Cancer Therapeutics|May 7, 2015
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of NeuroblastomaAlicia M Waters, Jerry E Stewart, Venkatram R Atigadda, et al.
Aging Cell|February 1, 2022
Loss of circRNAs from the crh-1 gene extends the mean lifespan in Caenorhabditis elegansDavid Knupp, Brian G Jorgensen, Hussam Z Alshareef, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 28, 2011
Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathwaysJixia Li, Yeon-Yong Cho, Alyssa Langfald, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2019
Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced CancersRonald A Lubet, Brandy M Heckman-Stoddard, Jennifer T Fox, et al.
Molecular Cancer Therapeutics|May 2, 2006
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutationsRonald A Lubet, Konstantin Christov, Ming You, et al.
Msystems|November 21, 2017
Large-Scale Bioinformatics Analysis of <i>Bacillus</i> Genomes Uncovers Conserved Roles of Natural Products in Bacterial PhysiologyKirk J Grubbs, Rachel M Bleich, Kevin C Santa Maria, et al.
Oncology Reports|May 28, 2011
Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?Ronald A Lubet, Brandy M Heckman, Silvio L De Flora, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Oncology Reports|January 14, 2004
Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer preventionMark B Cope, Vernon E Steele, Ronald A Lubet, et al.
Molecular Cancer Therapeutics|February 14, 2016
Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic MalignanciesAlicia M Waters, Jerry E Stewart, Venkatram R Atigadda, et al.
Cancer Research|December 1, 1978
Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamineP J Becci, H J Thompson, C J Grubbs, et al.
Molecular Cancer Therapeutics|May 7, 2015
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of NeuroblastomaAlicia M Waters, Jerry E Stewart, Venkatram R Atigadda, et al.
Aging Cell|February 1, 2022
Loss of circRNAs from the crh-1 gene extends the mean lifespan in Caenorhabditis elegansDavid Knupp, Brian G Jorgensen, Hussam Z Alshareef, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 28, 2011
Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathwaysJixia Li, Yeon-Yong Cho, Alyssa Langfald, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2019
Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced CancersRonald A Lubet, Brandy M Heckman-Stoddard, Jennifer T Fox, et al.
Molecular Cancer Therapeutics|May 2, 2006
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutationsRonald A Lubet, Konstantin Christov, Ming You, et al.
Msystems|November 21, 2017
Large-Scale Bioinformatics Analysis of <i>Bacillus</i> Genomes Uncovers Conserved Roles of Natural Products in Bacterial PhysiologyKirk J Grubbs, Rachel M Bleich, Kevin C Santa Maria, et al.
Oncology Reports|May 28, 2011
Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?Ronald A Lubet, Brandy M Heckman, Silvio L De Flora, et al.
Pageof 16